Growth Capital • Machinery

Icos Capital Invests In PEF Technologies

On August 16, 2024, growth capital firm Icos Capital invested in machinery company PEF Technologies

Investment Context
  • This is Icos Capital’s 1st transaction in the Machinery sector.
  • This is Icos Capital’s 12th transaction in the Netherlands.

Explore All 190 Growth Capital Machinery Deals - Search the Database Free


Investment Summary

Date August 16, 2024
Target PEF Technologies
Sector Machinery
Investor(s) Icos Capital
Deal Type Growth Capital

Target Company

PEF Technologies

Enschede, Netherlands
PEF Technologies offers a wide range of food processing equipment for various needs of businesses of any level of production. PEF Technologies's nanoPEF is a completely new low-temperature food preservation technology. PEF Technologies was founded in 2018 and is based in Enschede, Netherlands.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

DESCRIPTION

Icos Capital is a specialist private equity firm focused on investments in clean technology. Icos looks for European companies that offer new, alternative scarce resources (water, energy) and more efficient industrial and consumer products. The firm looks to provide growth capital in the form of minority investments. Icos' target investment size is €1 to €5 million. Icos Capital is headquartered in Rotterdam, Netherlands.


Deal Context for Investor #
Overall 15 of 16
Sector: Machinery 1 of 1
Type: Growth Capital 12 of 13
Country: Netherlands 12 of 12
Year: 2024 3 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-01-30 NapiFeryn

Lodz, Poland

NapiFeryn is a innovator that developed and patented a unique technology for obtaining rapeseed protein from the side-streams of oil pressing. NapiFeryn was founded in 2014 and is based in Lodz, Poland.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-09-12 Abolis

Evry, France

Abolis is delivering high-impact innovations in biotechnologies that supports industries in their transition to a more sustainable production model by building a better future in collaboration with Nature. Abolis provides tailor-made industrial solutions based on natural and modified micro-organisms. Abolis was founded in 2014 and is based in Evry, France.

Buy -

Explore Related M&A Activity